Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:17506661n
Noun Named Entity
Categories: Biotechnology, Experimental cancer drugs, Articles without InChI source
EN
Eftilagimod alpha  etilagimod alpha  ImmuFact  IMP321
EN
Eftilagimod alpha is a large-molecule cancer drug being developed by the clinical-stage biotechnology company Immutep. Wikipedia
Definitions
Relations
Sources
EN
Eftilagimod alpha is a large-molecule cancer drug being developed by the clinical-stage biotechnology company Immutep. Wikipedia
experimental cancer drug Wikidata
IS A
experimental drug
Wikipedia
EN
Eftilagimod alpha
Wikidata
EN
etilagimod alpha
Wikipedia Redirections
EN
IMP321
Wikidata Alias
EN
ImmuFact, IMP321

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License